Uses of Effective Dose: The Good, the Bad, and the Future

被引:5
作者
Bushberg, Jerrold T. [1 ,2 ,3 ]
机构
[1] Univ Calif Davis, Dept Radiol, Sch Med, 2315 Stockton Blvd,FSSB 2500, Sacramento, CA 95817 USA
[2] Univ Calif Davis, Radiol & Radiat Oncol, Sch Med, 2315 Stockton Blvd,FSSB 2500, Sacramento, CA 95817 USA
[3] Natl Council Radiat Protect & Measurements, 7910 Woodmont Ave, Bethesda, MD 20814 USA
来源
HEALTH PHYSICS | 2019年 / 116卷 / 02期
关键词
National Council on Radiation Protection and Measurements; effective dose; International Commission on Radiological Protection; radiation dose; RADIATION PROTECTION; RISK; EQUIVALENT; CHILDHOOD; EXPOSURE; SCANS;
D O I
10.1097/HP.0000000000001014
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Effective dose (E) is a risk-adjusted dosimetric quantity developed by the International Commission on Radiological Protection. It is a key metric for practical management of the risk of stochastic health effects in a comprehensive radiation protection program. The International Commission on Radiological Protection and others have emphasized repeatedly that E is not intended to represent an actual radiation dose and should not be used as a risk-related metric for a specific person or population. The cancer risk uncertainties in the low-dose range and the underlying approximations, simplifications, and sex- and age-averaging used in generating E make it unsuitable for this purpose. However, in practice, medical imaging professionals and authors of peer-reviewed medical publications frequently and incorrectly use E as a surrogate for whole-body dose in order to calculate cancer risk estimates for specific patients or patient populations. This frequent misuse has popularized E for uses for which it was neither designed nor intended. Alternatives to E have been proposed that attempt to account for known age and sex differences in radiation sensitivity. E has also been proposed as a general indicator for communicating radiation risk to patients, if its limitations are kept in mind. Forthcoming guidance from the International Commission on Radiological Protection will likely clarify if, when, and how some form of E may be used as a rough indicator of the risk of a stochastic effect, possibly with some modifications for the substantial variations in risk known to exist with respect to age, sex, and population group.
引用
收藏
页码:129 / 134
页数:6
相关论文
共 45 条
[1]  
[Anonymous], USITC PUBL
[2]  
[Anonymous], 2008, AAPM REP, DOI DOI 10.37206/97
[3]  
[Anonymous], 2006, HLTH RISKS EXP LOW L
[4]  
Balonov M. I., 2012, Annals of the ICRP, V41, P129, DOI 10.1016/j.icrp.2012.06.002
[5]   MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry-Standardization of Nomenclature [J].
Bolch, Wesley E. ;
Eckerman, Keith F. ;
Sgouros, George ;
Thomas, Stephen R. .
JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (03) :477-484
[6]   Effective dose: a flawed concept that could and should be replaced [J].
Brenner, D. J. .
BRITISH JOURNAL OF RADIOLOGY, 2008, 81 (967) :521-523
[7]  
Brenner D. J., 2012, Annals of the ICRP, V41, P124, DOI 10.1016/j.icrp.2012.07.001
[8]   Effective dose: A useful concept in diagnostic radiology [J].
Brenner, David ;
Huda, Walter .
RADIATION PROTECTION DOSIMETRY, 2008, 128 (04) :503-508
[9]   Estimating Effective Dose for CT Using Dose-Length Product Compared With Using Organ Doses: Consequences of Adopting International Commission on Radiological Protection Publication 103 or Dual-Energy Scanning [J].
Christner, Jodie A. ;
Kofler, James M. ;
McCollough, Cynthia H. .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 194 (04) :881-889
[10]  
CLARKE SEM, 1994, J NUCL MED, V35, P187